Home Search

cybn - search results

If you're not happy with the results, please do another search

Cybin (CYBN) Announces Unprecedented Positive Phase 2 Data After Single Dose.

Conference call to discuss CYB003 interim results today, November 1, 2023 at 11:00 a.m. ET

Adding Cybin (CYBN) $0.46 to 2024 Top Psychedelic Stocks Watch List.

Steve Cohen from Point 72, Acquires 18,950,000 Shares of Cybin.

Cybin (CYBN) and Kernel Announce Results from Kernel Flow® Piloting of Feasibility Study Measuring Ketamine’s...

- Preliminary data confirm Flow's ability to successfully measure neuro-effect of ketamine over 10 days - - Results to...
Psychedelic Stock Review

Cybin (CYBN) Announces FDA Investigational New Drug Authorization of Cybin’s Sponsored Feasibility Study Using...

October 26, 2021 07:30 AM Eastern Daylight Time TORONTO--(BUSINESS WIRE)--Cybin Inc. (NEO:CYBN) (NYSE American:CYBN) (“Cybin” or the “Company”), a biotechnology...

Cybin (CLXPF CYBN) Banks $30 Million Overnight.

Cybin Announces Size and Pricing of Previously Announced Overnight Marketed Public Offering of Common Shares. LIVE QUOTE

Cybin (CLXPF CYBN) Gets $8.00 Price Target From H.C. Wainwright.

Advancing Multiple Psychedelics in Multiple Indications; Initiating With a Buy and $8 Price Target.
Psychedelic Stock Review

Wonderland Miami: Public Companies.

Plenty of public companies making an appearance. Way outnumbered by the experts and 'thought-leaders' from the medical community - but we can...
Psychedelic Stock Review

Psychedelic Investor Conferences.

Not Quite as Popular as the Bitcoin 2021 Conference Attended by 12,000 - But Worth Considering!
Greenbrook Health

Greenbrook Health Centers (GBNH) Changing the Way Depression is Treated.

Cybin Enters into Collaboration Agreement with Greenbrook TMS to Establish Mental Health Centers of Excellence https://youtu.be/yrr-wlFftT0

Latest article

Ardelyx (ARDX) Reports First Quarter 2024 Showing $204 Million in Cash!

When we added Ardelyx (ARDX) to the Watch List in November of 2022, the market cap near $80 million. Now it's...

GeoVax to Provide Corporate Update on Tuesday May 14, 2024.

Still our favorite biotech microcap, still our favorite management team, and our favorite risk to reward idea with a $4 million market...

NovaVax (NVAX) Roars Higher, Gaining 225% a $1.2 Billion Increase, at the Blink of...

Sanofi (SNY) Announces Partnership - $500 Million Upfront, plus $700 million in Milestones with NovaVax (NVAX). And some investors say Covid is...